Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases

E. M. Pogliani, A. Bozzani, F. Radaelli, D. Conte, M. T. Bardella, M. Colombi, M. Quatrini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Venous thrombosis in 2 patients with gastro-intestinal diseases (chronic liver disease and ulcerative colitis) is reported. A good clinical improvement was obtained after thrombolytic (urokinase) therapy without any haemorrhagic side-effect. A decrease in the plasma of the fast-acting antiplasmin has been correlated with urokinase thrombolytic effect in vivo. These preliminary reports suggest that thrombolytic drugs are a safe tool for the treatment also of thromboembolic complications in patients with potential haemorrhagic diathesis.

Original languageEnglish
Pages (from-to)268-273
Number of pages6
JournalPharmatherapeutica
Volume3
Issue number4
Publication statusPublished - 1982

Fingerprint

Intestinal Diseases
Thrombolytic Therapy
Urokinase-Type Plasminogen Activator
Venous Thrombosis
Hemorrhagic Disorders
Antifibrinolytic Agents
Fibrinolytic Agents
Ulcerative Colitis
Liver Diseases
Chronic Disease
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Pogliani, E. M., Bozzani, A., Radaelli, F., Conte, D., Bardella, M. T., Colombi, M., & Quatrini, M. (1982). Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases. Pharmatherapeutica, 3(4), 268-273.

Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases. / Pogliani, E. M.; Bozzani, A.; Radaelli, F.; Conte, D.; Bardella, M. T.; Colombi, M.; Quatrini, M.

In: Pharmatherapeutica, Vol. 3, No. 4, 1982, p. 268-273.

Research output: Contribution to journalArticle

Pogliani, EM, Bozzani, A, Radaelli, F, Conte, D, Bardella, MT, Colombi, M & Quatrini, M 1982, 'Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases', Pharmatherapeutica, vol. 3, no. 4, pp. 268-273.
Pogliani EM, Bozzani A, Radaelli F, Conte D, Bardella MT, Colombi M et al. Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases. Pharmatherapeutica. 1982;3(4):268-273.
Pogliani, E. M. ; Bozzani, A. ; Radaelli, F. ; Conte, D. ; Bardella, M. T. ; Colombi, M. ; Quatrini, M. / Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases. In: Pharmatherapeutica. 1982 ; Vol. 3, No. 4. pp. 268-273.
@article{59c2845751e64df998fc8262f4846087,
title = "Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases",
abstract = "Venous thrombosis in 2 patients with gastro-intestinal diseases (chronic liver disease and ulcerative colitis) is reported. A good clinical improvement was obtained after thrombolytic (urokinase) therapy without any haemorrhagic side-effect. A decrease in the plasma of the fast-acting antiplasmin has been correlated with urokinase thrombolytic effect in vivo. These preliminary reports suggest that thrombolytic drugs are a safe tool for the treatment also of thromboembolic complications in patients with potential haemorrhagic diathesis.",
author = "Pogliani, {E. M.} and A. Bozzani and F. Radaelli and D. Conte and Bardella, {M. T.} and M. Colombi and M. Quatrini",
year = "1982",
language = "English",
volume = "3",
pages = "268--273",
journal = "Pharmatherapeutica",
issn = "0308-051X",
number = "4",

}

TY - JOUR

T1 - Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases

AU - Pogliani, E. M.

AU - Bozzani, A.

AU - Radaelli, F.

AU - Conte, D.

AU - Bardella, M. T.

AU - Colombi, M.

AU - Quatrini, M.

PY - 1982

Y1 - 1982

N2 - Venous thrombosis in 2 patients with gastro-intestinal diseases (chronic liver disease and ulcerative colitis) is reported. A good clinical improvement was obtained after thrombolytic (urokinase) therapy without any haemorrhagic side-effect. A decrease in the plasma of the fast-acting antiplasmin has been correlated with urokinase thrombolytic effect in vivo. These preliminary reports suggest that thrombolytic drugs are a safe tool for the treatment also of thromboembolic complications in patients with potential haemorrhagic diathesis.

AB - Venous thrombosis in 2 patients with gastro-intestinal diseases (chronic liver disease and ulcerative colitis) is reported. A good clinical improvement was obtained after thrombolytic (urokinase) therapy without any haemorrhagic side-effect. A decrease in the plasma of the fast-acting antiplasmin has been correlated with urokinase thrombolytic effect in vivo. These preliminary reports suggest that thrombolytic drugs are a safe tool for the treatment also of thromboembolic complications in patients with potential haemorrhagic diathesis.

UR - http://www.scopus.com/inward/record.url?scp=0020416135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020416135&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 268

EP - 273

JO - Pharmatherapeutica

JF - Pharmatherapeutica

SN - 0308-051X

IS - 4

ER -